Skip to main content

Advertisement

Log in

Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

Lymphoma is the third most common malignancy in children (0–14 years) and the first in adolescents (15–19 years). This population-based study—the largest ever done in Spain—analyses incidence and survival of lymphomas among Spanish children and adolescents.

Patients and methods

1664 lymphoma cases (1983–2007) for incidence and 1030 for survival (1991–2005) followed until 31/12/2010, were provided by 11 cancer registries. Age-adjusted incidence rates (ASRw) to the world standard population were obtained; incidence trends were modelled using the Joinpoint programme, observed survival (OS) was estimated with Kaplan–Meier and trends tested with a log-rank test. Results are presented according to the International Classification of Childhood Cancer-3.

Results

In Spain, the ASRw0–14 for lymphomas was 17.5 per 1.000.000 child-years and 50.0 the specific rate for adolescents. Overall incidence increased significantly during 1983–1997 with no increases thereafter. Patients over 9 years old showed significant rising trends for all subtypes, except for Burkitt lymphoma (BL) in adolescents. During 2001–2005 (age 0–19 years), 5-year OS was 94 (90–98), 73 (64–83) and 86 (78–94) for Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) and BL, respectively. No improvement in survival was found. The incidence in Spain was higher than overall European rates, but within the range of that in Southern Europe. Comparing OS in Spain 1991–1995 and 2001–2005 with results for Europe of the Automated Childhood Cancer Information System (ACCIS) (1988–1997) and the European cancer registry-based study on survival and care of cancer patients (EUROCARE) (2000–2007), it was similar for HL and lower for NHL and BL.

Conclusions

Systematic monitoring and analysis of lymphoma paediatric data would provide clinical and epidemiological information to improve the health care of these patients and the outcomes for these malignancies in Spain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–2010: a population-based registry study. Lancet Oncol. 2017;18(6):719–31.

    Article  Google Scholar 

  2. Swerdlow SH, Campo E, Pileri SA, Lee Harris N, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.

    Article  CAS  Google Scholar 

  3. Minard-Colin V, Brugieres L, Reiter A, Cairo MS, Gross TG, Woessmann W, et al. Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead. J Clin Oncol. 2015;33(27):2963–74.

    Article  CAS  Google Scholar 

  4. Clavel J, Steliarova-Foucher E, Berger C, Danon S, Valerianova Z. Hodgkin’s disease incidence and survival in European children and adolescents (1978–1997): report from the automated cancer information system project. Eur J Cancer. 2006;42(13):2037–49.

    Article  CAS  Google Scholar 

  5. Izarzugaza MI, Steliarova-Foucher E, Martos MC, Zivkovic S. Non-Hodgkin’s lymphoma incidence and survival in European children and adolescents (1978–1997): report from the automated childhood cancer information system project. Eur J Cancer. 2006;42(13):2050–63.

    Article  Google Scholar 

  6. Perkins SL; Morris SW. Biology and pathology of pediatric non-Hodgkin lymphoma. In: Weinstein HJ, Hudson MM, Link MP, editors. Pediatric Lymphomas. Berlin Heidelberg: Springer; 2007. p. 91–140

  7. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103(7):1457–67.

    Article  Google Scholar 

  8. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):35–47.

    Article  Google Scholar 

  9. Peris-Bonet R, Salmerón D, Martínez-Beneito MA, Galceran J, Marcos-Gragera R, Felipe S, et al. Childhood cancer incidence and survival in Spain. Ann Oncol Off J Eur Soc Med Oncol. 2010;21(suppl 3):iii103–10.

    Google Scholar 

  10. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.

  11. Instituto Nacional de Estadistica. (Spanish Statistical Office). http://www.ine.es/. Cited 05 Dec 2017

  12. National Cancer Institute. Joinpoint regression program—surveillance research program. 2015. http://surveillance.cancer.gov/joinpoint/.

  13. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112(2):416–32.

    Article  Google Scholar 

  14. Linet MS, Brown LM, Mbulaiteye SM, Check D, Ostroumova E, Landgren A, et al. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0–19 years. Int J Cancer. 2016;138(8):1862–74.

    Article  CAS  Google Scholar 

  15. Georgakis MK, Karalexi MA, Agius D, Antunes L, Bastos J, Coza D, et al. Incidence and time trends of childhood lymphomas: findings from 14 Southern and Eastern European cancer registries and the Surveillance, Epidemiology and End Results, USA. Cancer Causes Control. 2016;27(11):1381–94.

    Article  Google Scholar 

  16. Stiller CA, Parkin DM. International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol. 1990;4(3):303–24.

    Article  CAS  Google Scholar 

  17. Stiller CA, Desandes E, Danon SE, Izarzugaza I, Ratiu A, Vassileva-Valerianova Z, et al. Cancer incidence and survival in European adolescents (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2006–18.

    Article  CAS  Google Scholar 

  18. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.

    Article  Google Scholar 

  19. Mcnally RJQ, Parker L. Environmental factors and childhood acute leukemias and lymphomas. Leuk Lymphoma. 2006;47(4):583–98.

    Article  Google Scholar 

  20. Shapiro RS. Malignancies in the setting of primary immunodeficiency: implications for hematologists/oncologists. Am J Hematol. 2011;86:48–55.

    Article  Google Scholar 

  21. Horesh N, Horowitz NA. Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J. 2014;5(4):e0038.

    Article  Google Scholar 

  22. Sankila R, Martos Jimenez MC, Miljus D, Pritchard-Jones K, Steliarova-Foucher E, Stiller C. Geographical comparison of cancer survival in European children (1988–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):1972–80.

    Article  CAS  Google Scholar 

  23. Walsh PM, Byrne J, Capra M, Comber H. Childhood cancer survival in Ireland: temporal, regional and deprivation-related patterns. Eur J Cancer. 2011;47(12):1852–62.

    Article  Google Scholar 

  24. Schindler M, Belle FN, Grotzer MA, von der Weid NX, Kuehni CE. Childhood cancer survival in Switzerland (1976–2013): time-trends and predictors. Int J Cancer. 2017;140(1):62–74.

    Article  CAS  Google Scholar 

  25. Karim-Kos HE, Hackl M, Mann G, Urban C, Woehrer A, Slavc I, et al. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994–2011. Cancer Epidemiol. 2016;42:72–81.

    Article  Google Scholar 

  26. Madanat-Harjuoja LM, Pokhrel A, Kivivuori SM, Saarinen-Pihkala UM. Childhood cancer survival in Finland (1953–2010): a nation-wide population-based study. Int J Cancer. 2014;135(9):2129–34.

    Article  CAS  Google Scholar 

  27. Pulte D, Gondos A, Brenner H. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990–2004. J Natl Cancer Inst. 2008;100(18):1301–9.

    Article  Google Scholar 

  28. Peris Bonet R, Pardo Romaguera E, Muñoz López A, Sayas Sanchez, Valero Poveda S. Cáncer infantil en España. Estadísticas 1980-2014. Registro Español de Tumores Infantiles (RETI-SEHOP). Valencia: Universidad de Valencia; 2017. http://www.uv.es/rnti. Accesed 18 Jul 2017.

Download references

Acknowledgements

This work was supported by FIS (PI 061742) and (PI 10/01617); Enriqueta Villavecchia Foundation; Red de Investigación Temática en Cáncer RD12/0036/0056 (RMG) and RD12/0036/0053 (RPB and JG); and CIBERESP (predoctoral contract to MS). The authors thank E Pardo and A Muñoz for their contribution to the analysis and the critic review of the manuscript.

The Spanish Childhood Cancer Epidemiology Working Group for this study includes also the following cancer registries and collaborators: Albacete (E. Almar, A. Mateos), Asturias (J. R. Quirós), Basque Country (L. Gil, A. López de Munain), Childhood Cancer Registry of the Comunitat Valenciana (C. Sabater, M. Vicente), Girona (R. Marcos-Gragera, L. Vilardell), Granada (M. Rodríguez-Barranco, D. Y. Chang), Mallorca (P. Franch, M. Ramos), Murcia (C. Navarro, M. D. Chirlaque), Navarra (M. Guevara, R. Burgui), Tarragona (M. Carulla, A. Ameijide), Zaragoza (C. Martos) and the Spanish Registry of Childhood Tumours (RETI-SEHOP) (E. Pardo, A. Muñoz).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to R. Marcos-Gragera.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

The members of The Spanish Childhood Cancer Epidemiology Working Group are listed in Acknowledgements section.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marcos-Gragera, R., Solans, M., Galceran, J. et al. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years. Clin Transl Oncol 20, 1289–1301 (2018). https://doi.org/10.1007/s12094-018-1860-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-018-1860-1

Keywords

Navigation